LAS VEGAS, NV, Aug. 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – One World Pharma Inc. (OTC: OWPC), “OWP,” a U.S. based, fully licensed, pure-play hemp and cannabis ingredient producer in Colombia, is pleased to announce that the Company has completed its first THC harvest. The harvest utilized a THC quota granted to One World Pharma by the Colombian government.
OWP received its THC quota in December of 2019 and planted the psychoactive seeds in February of this year. The Company is one of only seventeen companies of the 246 licensed operators in Colombia to be able to register THC strains. The crops were harvested, dried, and analyzed for authenticity in July.
The harvest initiates the process of the Company authenticating its genetics and protecting its intellectual property. Most importantly, the successful completion of a full THC harvest allows the Company to now approach companies in legal countries which allow THC for medicinal use or pharmaceutical companies in need of THC ingredients for research and product development.
“This first harvest is a milestone of significant importance for One World Pharma,” stated Isiah Thomas, CEO, One World Pharma. “It is also a strong testament to our collaborative relationship with the Colombian government and its highly skilled indigenous population.”
“With this crop fully harvested and authenticated, we are now well-positioned to grow crops at scale in Latin America. This is the next and perhaps most important step in our ultimate goal to sell the best raw cannabis ingredients around the world,” added Thomas.
About One World Pharma
Formed in 2017, One World Pharma Inc. (“OWP”) is a fully licensed global supplier of high-quality hemp-derived ingredients for use in the manufacturing of Consumer Packaged Goods (CPGs) and Over-the-Counter (OTC) products. OWP offers a reliable and sustainable supply chain for chemical formulators, food & beverage producers as well as beauty product manufacturers worldwide. The company maintains corporate offices in Las Vegas, NV and Bogota Colombia and a facility in Popayan, Colombia.
One World Pharma Investor Relations & Financial Media
Kurt Divich, CEO
Integrity Media Inc.
team@integritymedia.com
Toll Free: (888) 216-3595
www.IntegrityMedia.com
Information about Forward-Looking Statements
This press release contains "forward-looking statements" that include information relating to future events. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company's need for additional funding, the demand for the Company's products, governmental regulation of the cannabis industry, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, risks related to operating in Colombia, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other risks that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting One World Pharma, please refer to the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on May 29, 2020, which is available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.